PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 7196877

  • 1. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA, Urban MD, Gutai JP, Migeon CJ.
    Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
    [Abstract] [Full Text] [Related]

  • 2. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.
    Hughes IA, Winter JS.
    J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027
    [Abstract] [Full Text] [Related]

  • 3. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [Abstract] [Full Text] [Related]

  • 4. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
    Lippe BM, LaFranchi SH, Lavin N, Parlow A, Coyotupa J, Kaplan SA.
    J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
    [No Abstract] [Full Text] [Related]

  • 5. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
    Frisch H, Parth K, Schober E, Swoboda W.
    Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
    [Abstract] [Full Text] [Related]

  • 6. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
    von Schnakenburg K, Bidlingmaier F, Knorr D.
    Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
    [Abstract] [Full Text] [Related]

  • 7. Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia.
    Strott CA, Yoshimi T, Bardin CW, Lipsett MB.
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1085-8. PubMed ID: 5660261
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.
    Huseman CA, Varma MM, Blizzard RM, Johanson A.
    J Pediatr; 1977 Apr; 90(4):538-42. PubMed ID: 839364
    [Abstract] [Full Text] [Related]

  • 9. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 10. Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.
    Solomon IL, Schoen EJ, Donelan L, Brandt-Erichsen D.
    J Clin Endocrinol Metab; 1975 Mar; 40(3):355-62. PubMed ID: 163840
    [Abstract] [Full Text] [Related]

  • 11. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS, McNeel R, Barrett GN, Holcombe JH, Kirkland RT, Clayton GW.
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract] [Full Text] [Related]

  • 12. Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia.
    Hatun S, Yordam N, Calikoğlu AS.
    Eur J Endocrinol; 1994 Nov; 131(5):504-8. PubMed ID: 7952161
    [Abstract] [Full Text] [Related]

  • 13. [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].
    von Schnakenburg K, Bidingmaier F, Knorr D.
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):579-80. PubMed ID: 876244
    [No Abstract] [Full Text] [Related]

  • 14. The use of plasma androstenedione in monitoring therapy of patients with congenital adrenal hyperplasia.
    Cavallo A, Corn C, Bryan GT, Meyer WJ.
    J Pediatr; 1979 Jul; 95(1):33-7. PubMed ID: 480011
    [Abstract] [Full Text] [Related]

  • 15. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA, Winter JS.
    J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
    [Abstract] [Full Text] [Related]

  • 16. 170H-progesterone rhythms in congenital adrenal hyperplasia.
    Young MC, Robinson JA, Read GF, Riad-Fahmy D, Hughes IA.
    Arch Dis Child; 1988 Jun; 63(6):617-23. PubMed ID: 3389891
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of androgens and 17 alpha-OH-progesterone as an index of the adequacy of treatment in congenital adrenal hyperplasia.
    Ilondo MM, Vanderschueren-Lodeweyckx M, Pizarro M, Vlietinck R, Malvaux P, Eggermont E, Eeckels R.
    Horm Res; 1983 Jun; 18(4):175-85. PubMed ID: 6227545
    [Abstract] [Full Text] [Related]

  • 18. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
    Granoff AB.
    J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
    [Abstract] [Full Text] [Related]

  • 19. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
    McKenna TJ, Jennings AS, Liddle GW, Burr IM.
    J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
    [Abstract] [Full Text] [Related]

  • 20. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
    Hendricks SA, Lippe BM, Kaplan SA, Lavin N, Mayes DM.
    Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.